CONTACT

Hyperion Therapeutics, Inc., a privately held specialty pharmaceutical company co-markets AMMONUL® (sodium phenylacetate and sodium benzoate) Injection 10%/10% and BUPHENYL® (sodium phenylbutyrate).  Hyperion can be reached at:

CORPORATE PHONE: 415.398.4548
CORPORATE EMAIL: kim.gray@hyperiontx.com

For medical information, product safety issues, adverse event reporting, or other inquiries, call Ucyclyd Pharma, Inc. at 1.888.829.2593